JOSEPH ADKINS: Open Payments
NPI 1841847720 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 29 payments from 12 companies in 2025. Trend: 2023 $1,246 · 2024 $998 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 6 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| Boston Scientific Corporation | 3 | $87 |
| Amgen Inc. | 3 | $55 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| PFIZER INC. | 2 | $42 |
| Alvogen Inc | 2 | $42 |
| Indivior Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Globus Medical, Inc. | 1 | $20 |
Products named: HYQVIA, Intracept, XTAMPZA, Belbuca, EVENITY, INGREZZA, NURTEC ODT, TERIPARATIDE.
Industry payments across FL — which companies pay providers there.
